
ACS Medicinal Chemistry Letters p. 1335 - 1341 (2020)
Update date:2022-08-02
Topics:
Hiramatsu, Atsushi
Hirooka, Yasuo
Hisaichi, Katsuya
Imagawa, Akira
Iwaki, Yuzo
Katoh, Makoto
Kobayashi, Juta
Komichi, Yuka
Maeda, Tatsuo
Matsumura, Naoya
Moriguchi, Hideki
Nakatani, Shingo
Nishiyama, Taihei
Ohhata, Akira
Okabe, Yasuyuki
Okada, Masahiro
Ota, Hiroto
Saga, Hiroshi
Sugiyama, Tetsuya
Watanabe, Toshihide
Yamamoto, Shingo
Lysophosphatidic acid (LPA) is a bioactive lipid mediator that elicits a number of biological functions, including smooth muscle contraction, cell motility, proliferation, and morphological change. LPA is endogenously produced by autotaxin (ATX) from extracellular lysophosphatidylcholine (LPC) in plasma. Herein, we report our medicinal chemistry effort to identify a novel and highly potent ATX inhibitor, ONO-8430506 (20), with good oral availability. To enhance the enzymatic ATX inhibitory activity, we designed several compounds by structurally comparing our hit compound with the endogenous ligand LPC. Further optimization to improve the pharmacokinetic profile and enhance the ATX inhibitory activity in human plasma resulted in the identification of ONO-8430506 (20), which enhanced the antitumor effect of paclitaxel in a breast cancer model.
View MoreZhejiang Newfine Industry Co.,Ltd.
Contact:+86-573-82262042
Address:No.225,Dongqing Road, garoms@163.com
Reliable Pharma Technology (Shanghai) Co., Ltd.
Contact:0086-21-67676847-8008
Address:Lane 1500, No.68, Xinfei Road, Songjiang District, Shanghai, 201611, P.R.China.
NanJing Rate Biochemicals CO., LTD
Contact:+86-25-84931986
Address:NO. 1 Hongjing Road,Jiangning Science Park,Nanjing,China
Hangzhou Yanshan Chemical Co.,Ltd.
Contact:86-571- 87698076
Address:Room 1001, #1 Building, Zhongtian MCC, No.2 Youzhinong, Wenyi West Road, Xihu District, Hangzhou, China
taizhou creating bio-pharm co.,ltd.
Contact:+86- 576- 88827176
Address:715 room ,unit A.junyue Building,Jiaojiang,Taizhou,Zhejiang,China
Doi:10.1021/ja00018a040
(1991)Doi:10.1016/j.bmcl.2011.10.099
(2012)Doi:10.1016/j.tetlet.2005.03.193
(2005)Doi:10.1016/j.inoche.2011.10.004
(2012)Doi:10.1055/s-0031-1289570
(2011)Doi:10.1021/acs.orglett.1c01177
(2021)